LMP2-DC Vaccine Elicits Specific EBV-LMP2 Response to Effectively Improve Immunotherapy in Patients with Nasopharyngeal Cancer.Yi Zeng, Hui Lin, Jiao Lan et al.|PubMed|2020Cited by 17